The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2022 | Lung cancer highlights at BTOG 2022
Frank McCaughan, MRCP(UK), MD, PhD, FRCP, University of Cambridge, Cambridge, UK, discusses his highlights at the 20th Annual British Thoracic Oncology Group (BTOG) Conference, including prehabilitation, as well as trial data demonstrating its benefits in patients with lung cancer. He additionally highlights advances in the perioperative space, where the co-morbidities of patients need to be considered. This interview took place at the 20th Annual BTOG Conference 2022.
